CHAPTER 1. INTRODUCTION
1.1.Market Definition
1.2.Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2.Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5.Degree of Competition
3.3.PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Rising number of partnerships and collaborations between companies
4.1.2. Increasing focus on developing alternatives for animal testing models
4.1.3. Rise in research funding and venture capital investments
4.2. Market Restraints & Challenges
4.2.1.The complexity of organs on chips models
4.2.2. Issues related to the incorporation of organs on chips technologies
4.3. Market Opportunities
4.3.1. Growing focus on drug discovery activities
4.3.2. Development of multiple organs on a chip model
CHAPTER 5. GLOBAL ORGAN ON CHIPS MARKET– BY OFFERING
5.1. Introduction
5.2. Products
5.3. Services
CHAPTER 6. GLOBAL ORGAN ON CHIPS MARKET – BY TYPE
6.1. Introduction
6.3. Kidney
6.4. Lung
6.5. Heart
6.6. Other Organs
CHAPTER 7. GLOBAL ORGAN ON CHIPS MARKET – BY APPLICATION
7.1. Introduction
7.2. Drug Discovery
7.3. Physiological Model Development
7.4. Toxicology Research
CHAPTER 8. GLOBAL ORGAN ON CHIPS MARKET – BY END USER
8.1. Introduction
8.2. Cosmetics Industry
8.3. Pharmaceutical & Biotechnology Companies
8.4. Academic & Research Institutes
8.5. Other End Users
CHAPTER 9. GLOBAL ORGAN ON CHIPS MARKET - BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. The U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. APAC
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10. GLOBAL ORGAN ON CHIPS MARKET - COMPANY PROFILES
10.1. Nortis Bio
10.2. Synvivo
10.3. Tissuse
10.4. Mimetas B.V
10.5. Ascendance Biotechnology, Inc.
10.6. Emulate, Inc.
10.7. Kirkstall
10.8. Hurel Corporation
10.9. InSphero AG
10.10. Axosim Technologies LLC
10.11. CN Bio Innovations
10.12. Tara Biosystems
10.13. Organovo Holdings, Inc.
CHAPTER 11. GLOBAL ORGAN ON CHIPS MARKET - COMPETITIVE
LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12. MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13. APPENDIX
13.1. List of Tables
13.2. List of Figures
